Alpha 2.0
Login Register
» Authors » Bianca Hemmingsen

Bianca Hemmingsen

Explore the profile of Bianca Hemmingsen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 904
Followers 0
Related Specialties
General Medicine
Health Services
Endocrinology
Top 10 Co-Authors
Christian Gluud
Allan Vaag
Jorn Wetterslev
Soren S Lund
Bernd Richter
Maria-Inti Metzendorf
Thomas Almdal
Sten Madsbad
Lise Tarnow
Thomas P Almdal
Published In
Cochrane Database Syst Rev
BMJ Open
Lancet Diabetes Endocrinol
BMJ
Ugeskr Laeger
Affiliations
Soon will be listed here.
Recent Articles
1.
Mpox and diabetes: a needed public health research agenda
Manne-Goehler J, Lewis R, Hemmingsen B
Lancet Diabetes Endocrinol . 2025 Feb; 13(3):176-177. PMID: 40015809
No abstract available.
2.
Pregnancy, childbirth and the postpartum period: opportunities to improve lifetime outcomes for women with non-communicable diseases
Ramson J, Williams M, Afolabi B, Colagiuri S, Finlayson K, Hemmingsen B, et al.
Med J Aust . 2024 Sep; 221(7):350-353. PMID: 39307578
No abstract available.
3.
Diabetes as a risk factor for tuberculosis disease
Franco J, Bongaerts B, Metzendorf M, Risso A, Guo Y, Pena Silva L, et al.
Cochrane Database Syst Rev . 2024 Aug; 8:CD016013. PMID: 39177079
Background: Tuberculosis (TB) is amongst the leading causes of death from an infectious disease, with an estimated 1.3 million deaths from TB in 2022. Approximately 25% of the global population...
4.
Undernutrition as a risk factor for tuberculosis disease
Franco J, Bongaerts B, Metzendorf M, Risso A, Guo Y, Pena Silva L, et al.
Cochrane Database Syst Rev . 2024 Jun; 6:CD015890. PMID: 38860538
Background: Tuberculosis (TB) is a leading cause of mortality due to an infectious disease, with an estimated 1.6 million deaths due to TB in 2022. Approximately 25% of the global...
5.
Kidney health within the broader non-communicable disease agenda
Slama S, Luyckx V, Hemmingsen B
Nat Rev Nephrol . 2024 May; 20(7):424-425. PMID: 38760475
No abstract available.
6.
A WHO key informant language survey of people with lived experiences of diabetes: Media misconceptions, values-based messaging, stigma, framings and communications considerations
Hunt D, Lamb K, Elliott J, Hemmingsen B, Slama S, Scibilia R, et al.
Diabetes Res Clin Pract . 2022 Oct; 193:110109. PMID: 36183868
Aims: This study aimed to learn from people with lived experiences of diabetes to raise the quality of diabetes communications. Methods: An online key informant survey for people (18+) with...
7.
The WHO Global Diabetes Compact: a new initiative to support people living with diabetes
Hunt D, Hemmingsen B, Matzke A, Varghese C, Hammerich A, Luciani S, et al.
Lancet Diabetes Endocrinol . 2021 Apr; 9(6):325-327. PMID: 33862005
No abstract available.
8.
(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus
Hemmingsen B, Metzendorf M, Richter B
Cochrane Database Syst Rev . 2021 Mar; 3:CD013498. PMID: 33662147
Background: People with type 1 diabetes mellitus (T1DM) need treatment with insulin for survival. Whether any particular type of (ultra-)long-acting insulin provides benefit especially regarding risk of diabetes complications and...
9.
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
Ipsen E, Madsen K, Chi Y, Pedersen-Bjergaard U, Richter B, Metzendorf M, et al.
Cochrane Database Syst Rev . 2020 Nov; 11:CD013516. PMID: 33210751
Background: The term prediabetes is used to describe a population with an elevated risk of developing type 2 diabetes mellitus (T2DM). With projections of an increase in the incidence of...
10.
Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial
Hansen C, Lundby-Christiansen L, Tarnow L, Gluud C, Hedetoft C, Thorsteinsson B, et al.
Cardiovasc Diabetol . 2020 Sep; 19(1):150. PMID: 32979921
Background: Metformin has been shown to have both neuroprotective and neurodegenerative effects. The aim of this study was to investigate the effect of metformin in combination with insulin on cardiovascular...